Drug
Pal 40 Active
Pal 40 Active: highest development phase Phase 3, developed by Abbott Laboratories. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Abbott Laboratories
Trials
| Drug | Phase | Indication |
|---|---|---|
| PAL-40 Active NCT00032435 | Phase 3 | End Stage Renal Disease |
Latest
No recent events.
Follow Pal 40 Active on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.